We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > Rubella

News List

Micron Progresses with Clinical Evaluation of Measles-Rubella Vaccination Technology americanpharmaceuticalreview
September 03, 2020
Micron Biomedical recently received a second tranche of funding ($2.6M) to continue clinical development of its microneedle-based technology for measles and rubella vaccination from the Bill & Melinda Gates Foundation.
Wistar and Batavia Collaborate to Manufacture Rubella Vaccine contractpharma
May 04, 2020
The Wistar Institute and Batavia Biosciences have launched a strategic collaboration aimed to streamline the clinical grade manufacture and global distribution of Wistar’s rubella vaccine seed stock commonly known as RA 27/3.
WHO declares Sri Lanka free from Rubella biospectrumasia
September 10, 2018
WHO had declared Sri Lanka as Malaria-free country in 2015, Filaria-free country in 2016 and Maternal and Neonatal Tetanus (MNT) -free country in 2017.